- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04634032
Gene Expression and DNA Variation Analysis of Sacs to Identify the Pathophysiology of Indirect Inguinal Hernia
The aim of the project is to show that gene expression levels change in at least one of the GATA6 and T-box transcription factor 3 (TBX3) genes in indirect inguinal hernia sacs, thus revealing that this pathway causes an error in the sac closure pathway.
Indirect inguinal hernia is an important condition for human health as it is common in the community and can lead to life-threatening or permanent loss of function. In addition, since the treatment is performed surgically, the follow-up and treatment process of the patients should be managed carefully in terms of complications and costs. By explaining the mechanisms of the occurrence of this disease, important steps will be taken in terms of both human health and the development of science. Moreover, the data to be collected may open new horizons in the treatment of inguinal hernia.
20 inguinal hernia patients those consecutively applied to Trakya University Medical Faculty Department of Pediatric Surgery and 20 circumcision patients as control group will be included in the study.
Study Overview
Status
Intervention / Treatment
Detailed Description
Indirect inguinal hernia is one of the pathologies that is widely researched in national and international studies because of its high prevalence in the community and its life-threatening or permanent loss of function. However, no point has been reached regarding the etiology of this disease and a consensus has been reached.
The investigators believe that the study will contribute to the explanation of the formation mechanisms of the mentioned disease. Considering the high prevalence of this disease and its potential for life-threatening, the investigators anticipate that the analysis of the relevant genes for the Turkish population will make significant contributions to the public health. In the literature, analysis of GATA6 SNPs in the Chinese population has subsequently associated certain polymorphisms with indirect inguinal hernia. It is also been stated that TBX3 gene pathologies may be associated with inguinal hernia.
However, there is no study in the literature about the patent processus vaginalis expression levels of these genes. There is no study on the SNP analysis of these genes in Turkish population. For these reasons, the first time the expression / SNP analysis of the specified genes in Turkish society will be carried out will make an additional contribution to scientific knowledge. As stated clearly in the studies, the implementation of medical treatment of indirect inguinal hernia may change the approach of the pediatric surgical community to indirect inguinal hernia. In order for medical treatment to be carried out, the formation pathways and genetic origins of the disease must be clearly revealed.
Investigating the relationship of GATA6 and TBX3 genes, which are known to be involved in connective tissue homeostasis, with the mechanisms of indirect inguinal hernia formation, will contribute to the studies in the literature and is important in terms of revealing whether the treatment of these diseases can be performed medically in the future.
The study aims to reveal that gene expression levels in indirect inguinal hernia sacs due to SNPs in at least one of the GATA6 and TBX3 genes, thus causing an error in the sac closure pathway. The hypothesis of the study; It is stated that the gene expression levels of at least one of GATA6 and TBX3 in the sacs of inguinal hernia patients are altered.
The primary goal of this study is; To determine the level of GATA6 and TBX3 gene expression in sacs obtained from indirect inguinal hernia patients. The secondary goal is to investigate SNPs in the leukocytes of these patients and to investigate whether the genetic elements in our hypothesis in these diseases are regulated by different genes acting as transcription factors.
Considering that indirect inguinal hernia poses significant health risks, especially in children, it is predicted that the results to be obtained may contribute to clarification of the etiology and non-invasive methods other than surgery.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Edirne, Turkey, 22030
- Trakya University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- to accept to participate the study
- pediatric age
- isolated indirect inguinal hernia patient with no additional systemic/congenital disease
- patients requesting circumcision procedure with no additional systemic/congenital disease
Exclusion Criteria:
- patients with any syndromic disease
- patients with hypospadias
- patients with undescended testes
- patients with umbilical hernia
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hernia
Patients planned to undergo routine indirect inguinal hernia repair procedure
|
mRNA expression and SNP analysis from samples
Peripheral blood sampling for SNP analysis
|
|
Control
Patients planned to undergo routine circumcision procedure
|
mRNA expression and SNP analysis from samples
Peripheral blood sampling for SNP analysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gene expression and Single Nucleotide Polymorphism analysis
Time Frame: up to 3 months after completion of the study
|
Determining the varieties of messenger ribonucleic acid (mRNA) expression levels between groups and possible Single Nucleotide Polymorphisms (SNP)
|
up to 3 months after completion of the study
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Oguz Kizilkaya, Trakya University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HerniaOK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genetic Predisposition to Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling by invitationGenetic Predisposition to CancerItaly
-
MedneonEnrolling by invitation
-
Eunice Kennedy Shriver National Institute of Child...CompletedGenetic PredispositionUnited States
-
University of VirginiaCompleted
-
University of VirginiaActive, not recruiting
-
St. Jude Children's Research HospitalCompletedPediatric Cancer | Predisposition, GeneticUnited States
-
University Hospital TuebingenCompletedRare Diseases | Genetic PredispositionGermany
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedSmoking Cessation | Genetic PredispositionBrazil
-
St. Jude Children's Research HospitalRecruitingGenetic PredispositionUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingHCC | Genetic PredispositionItaly
Clinical Trials on mRNA expression and SNP analysis
-
Renmin Hospital of Wuhan UniversityNot yet recruitingStage III Colorectal CancerChina
-
Public Health EnglandCardiff University; Aneurin Bevan University Health BoardUnknownPneumonia | Sepsis | Cardiac Arrest | SIRS | Abdominal SepsisUnited Kingdom
-
Mayo ClinicCompletedMyocardial Infarction | Obesity | Breast Cancer | Osteoarthritis | Atrial Fibrillation | Graves Disease | Lung Cancer | Celiac Disease | Prostate Cancer | Colon Cancer | Diabetes Type 2United States
-
Maastricht University Medical CenterCompletedCorticosteroid Induced Ocular Hypertension/GlaucomaNetherlands
-
Esraa Hassan,MDSouth Egypt Cancer InstituteCompleted
-
Asfendiyarov Kazakh National Medical UniversityCompletedLymphoma | B Cell LeukemiaKazakhstan
-
Assiut UniversityNot yet recruiting
-
Keesler Air Force Base Medical CenterCompletedRheumatoid Arthritis
-
Asfendiyarov Kazakh National Medical UniversityCompletedEclampsia | Hemorrhagic StrokeKazakhstan
-
Asfendiyarov Kazakh National Medical UniversityCompletedIdiopathic ScoliosisKazakhstan